COOPER ($NYSE:COO): Their total revenue was reported to have increased by 10.3% to USD 930.2 million compared to the same period in the previous year; however, net income had decreased by 13.3% to USD 85.3 million.
The results showed impressive growth figures, with the stock opening at $378.1 and closing at $380.9, up 0.7% from the previous closing price of $378.1. This was driven by strong performances in both its CooperSurgical and CooperVision segments. This increase was mainly attributed to the double-digit revenue growth and improved gross margins.
Overall, the Cooper Companies’ impressive performance during the third quarter of FY2023 highlights the company’s strong fundamentals and resilient business model. With its robust financial performance, the company is well-positioned to benefit from future growth opportunities and continue delivering strong returns for its shareholders. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Cooper Companies. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cooper Companies. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cooper Companies. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Cooper Companies are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
GoodWhale has conducted an analysis of COOPER COMPANIES‘ financials and have concluded that they classify as a ‘gorilla’. This type of company achieves stable and high revenue or earning growth due to its strong competitive advantage. Investors who are interested in such a company may be high-net-worth individuals, institutions, or venture capitalists looking for a good investment with potential for growth. We have also determined that COOPER COMPANIES has a high health score of 8/10 with regard to its cashflows and debt, making them well-capable to safely ride out any crisis without the risk of bankruptcy. With regard to their financial performance, COOPER COMPANIES is strong in dividend, profitability, and medium in asset, growth. Overall, COOPER COMPANIES is a strong, financially healthy company with potential for growth, making it an attractive choice for investors. More…
Risk Rating Analysis
Star Chart Analysis
The Cooper Companies Inc and its competitors, Sonova Holding AG, Pfizer Inc, and Teleflex Inc, compete in the global medical device market. Sonova Holding AG is a leading manufacturer of hearing aids and other auditory products. Pfizer Inc is a leading manufacturer of pharmaceuticals, vaccines, and other health care products. Teleflex Inc is a leading manufacturer of medical devices and other health care products.
– Sonova Holding AG ($LTS:0QPY)
Sonova Holding AG is a global leader in providing hearing care solutions. The company has a market capitalization of 15.4 billion as of 2022 and a return on equity of 21.26%. Sonova’s products are sold in over 100 countries and the company has a strong presence in Europe, North America, and Asia Pacific. The company’s products include hearing aids, cochlear implants, and wireless communication solutions.
Pfizer Inc is a multinational pharmaceutical corporation. It is one of the world’s largest pharmaceutical companies. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhard. The company has its headquarters in New York City.
Pfizer’s market cap is $270.73 billion as of 2022. Its return on equity is 27.98%. The company manufactures and sells a broad range of pharmaceutical products, including prescription and over-the-counter drugs. The company’s products are sold in more than 150 countries.
Teleflex Inc is a medical device company that provides products and services for a variety of medical conditions. The company has a market cap of 10.2B as of 2022 and a Return on Equity of 8.5%. Teleflex Inc’s products and services include catheters, respiratory devices, and surgical instruments. The company serves patients, families, and healthcare professionals worldwide.
COOPER COMPANIES reported positive financial results for the third quarter of FY2023. Revenue rose 10.3% year-over-year to USD 930.2 million, but net income declined 13.3% to USD 85.3 million. Investors should closely monitor the company’s revenue and profit margins in the coming quarters to assess the health of the business.
Companies should also pay attention to their cash flow, balance sheet metrics, and other key performance indicators to get a better idea of the company’s financial performance. Overall, the company’s earnings report suggests that COOPER COMPANIES is in a healthy financial position and investors may be able to capitalize on the company’s current performance in the near future.